For example, key hereditary PTEN cancer-associated germline mutations and common somatic mutations with increased cancer risk have been identified in colorectal cancers [111, 113], breast cancers [114, 115], prostate cancers [116] and gliomas [117]. This evidence concerns the gene PTEN and breast carcinoma.